LATE BREAKING CLINICAL TRIAL SCHEDULE

Look for these exciting presentations, covering late-breaking clinical trials and featured research, representing the latest cutting-edge science in a wide range of cardiology subspecialties.

SATURDAY

The Apple Heart Study: Results Of A Large-scale, App-based Study To Identify Atrial Fibrillation Using A Smartwatch

PANACHE: Safety and Efficacy of Neladenoson Bialanate, a Partial Adenosine A1 Receptor Agonist, in Patients with Heart Failure and Preserved Ejection Fraction: Results from the PANACHE Randomized Controlled Trial

PIONEER-HF: Initiation of Angiotensin-Neprilysin Inhibition after Acute Decompensated Heart Failure: Results of the Open-Label Extension of the PIONEER-HF Trial

Hopeful Heart Trial: Blended Collaborative Care for Treating Heart Failure and Comorbid Depression: 12-Month Primary Outcomes from the Hopeful Heart Trial

CODIACS-QoL: Randomized Trial of Depression Screening After Acute Coronary Syndromes: Results from Comparison of Depression Identification After Acute Coronary Syndromes-Quality of Life and Cost Effectiveness

The HoT-PE Study: Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban

SUNDAY

PARTNER 3: Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients

Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality

COAPT: Mitral Regurgitation After MitraClip Implantation in Patients with Heart Failure and Secondary Mitral Regurgitation: Echocardiographic Outcomes from the COAPT Trial

COAPT: Quality of Life After Transcatheter Mitral-Valve Repair in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT trial

Outcomes of Transcatheter Aortic Valve Replacement with Balloon-Expandable Sapien3 Valve in Bicuspid Aortic Stenosis: An Analysis of the STS/TVT Registry

AUGUSTUS Trial: Trial to Evaluate the Safety of Apixaban versus Vitamin K Antagonist and Aspirin versus Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome and/or Percutaneous Coronary Intervention: Final Results

WRAP-IT: The World-Wide Randomized Antibiotic Envelope Infection Prevention Trial to Reduce Cardiac Implantable Electronic Device Infection

POET: Partial Oral Treatment of Left-Sided Infectious Endocarditis: Long Term Follow-up

MOMENTUM 3: Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3: Final Analysis

CardioMEMS PAS: Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure Patients in Clinical Practice; 1-Year Outcomes from the CardioMEMS Post-Approval Study

First Randomized Human Experience with a Ticagrelor Reversal Agent

The DEFINE PCI Trial: Blinded Physiologic Assessment of Residual Ischemia After Successful Angiographic Percutaneous Coronary Intervention

Lessons from the ADVANCE Registry: Impact of FFRCT on 1-Year Outcomes in Patients Evaluated

MRUSMI: Sonothrombolysis in ST Segment Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention: Final Results from the First Randomized Study in Humans

GLASSY: Impact of Ticagrelor Monotherapy Beyond One Month Versus Conventional Therapy On Adjudicated Ischemic And Bleeding Endpoints Following Drug Eluting Sent Implantation

MONDAY

The CLEAR Wisdom Trial: Efficacy and Safety of Bempedoic Acid Added to Maximally Tolerated Statins in Patients with Hypercholesterolemia and High Cardiovascular Risk

CREOLE Study: Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans

INFINITY: Primary Results of the Intensive versus Standard Ambulatory Blood Pressure Lowering to Lessen Functional Decline in the Elderly Trial

DECLARE: Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus Based on Ejection Fraction

REDUCE-IT: Reduction in Total Ischemic Events with Icosapent Ethyl in REDUCE-IT

The Safety and Efficacy of Femoral Access versus Radial Access for Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction

COACT Trial: Coronary Angiography after Cardiac Arrest

TREAT Trial: Efficacy of Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction

STOPDAPT-2 Trial: One-Month Dual Antiplatelet Therapy Followed by Clopidogrel Monotherapy versus Standard 12-Month Dual Antiplatelet Therapy with Clopidogrel After Drug-Eluting Stent Implantation

SMART-CHOICE: P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy in Patients Undergoing Implantation of Coronary Drug-eluting Stents

Alcohol AF: Impact of Alcohol Abstinence in Moderate Drinkers with Atrial Fibrillation

REVEAL: Impact of ADCY9 on Response to Anacetrapib Among 20,000 Participants in the HPS3/TIMI55-REVEAL Trial

ODYSSEY OUTCOMES: Lipoprotein(a) Lowering by Alirocumab Contributes to Total Events Reduction Independent of Low-Density Lipoprotein Cholesterol in the ODYSSEY OUTCOMES Trial

Insights from DECLARE – TIMI 58: Dapagliflozin and Outcomes in Patients with Peripheral Artery Disease

IRAD: Acute Aortic Dissection: Lessons Learned from 9000 Patients